These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23168929)

  • 21. A possible case of minimal hepatic encephalopathy treated successfully with lactulose.
    Spiegel DR; Surkin K
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E1. PubMed ID: 21304108
    [No Abstract]   [Full Text] [Related]  

  • 22. The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.
    Strauss E; da Costa MF
    Hepatogastroenterology; 1998; 45(21):900-4. PubMed ID: 9684155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifaximin for the treatment of hepatic encephalopathy.
    Lawrence KR; Klee JA
    Pharmacotherapy; 2008 Aug; 28(8):1019-32. PubMed ID: 18657018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.
    Abid S; Jafri W; Mumtaz K; Islam M; Abbas Z; Shah HA; Hamid S
    J Coll Physicians Surg Pak; 2011 Nov; 21(11):666-71. PubMed ID: 22078345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on management of patients with overt hepatic encephalopathy.
    Chacko KR; Sigal SH
    Hosp Pract (1995); 2013 Aug; 41(3):48-59. PubMed ID: 23948621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
    Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
    Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
    Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
    Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Special issues related to pharmacists in the Management of Hepatic Encephalopathy Advisory Board Meeting held in Las Vegas, Nevada, December 5, 2009. Introduction.
    Thompson JR
    Pharmacotherapy; 2010 May; 30(5 Pt 2):1S-3S. PubMed ID: 20412033
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination therapy for the treatment and prevention of hepatic encephalopathy.
    Mohammad RA; Regal RE; Alaniz C
    Ann Pharmacother; 2012 Nov; 46(11):1559-63. PubMed ID: 23092866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatric aspects of portal-systemic encephalopathy.
    Wiltfang J; Nolte W; Weissenborn K; Kornhuber J; Rüther E
    Metab Brain Dis; 1998 Dec; 13(4):379-89. PubMed ID: 10206828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study.
    Simón-Talero M; García-Martínez R; Torrens M; Augustin S; Gómez S; Pereira G; Guevara M; Ginés P; Soriano G; Román E; Sánchez-Delgado J; Ferrer R; Nieto JC; Sunyé P; Fuentes I; Esteban R; Córdoba J
    J Hepatol; 2013 Dec; 59(6):1184-92. PubMed ID: 23872605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study.
    Wunsch E; Szymanik B; Post M; Marlicz W; Mydłowska M; Milkiewicz P
    Liver Int; 2011 Aug; 31(7):980-4. PubMed ID: 21733087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.
    Ndraha S; Simadibrata M
    Acta Med Indones; 2010 Jul; 42(3):158-61. PubMed ID: 20724770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
    Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
    Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covert hepatic encephalopathy: agreement and predictive validity of different indices.
    Montagnese S; Balistreri E; Schiff S; De Rui M; Angeli P; Zanus G; Cillo U; Bombonato G; Bolognesi M; Sacerdoti D; Gatta A; Merkel C; Amodio P
    World J Gastroenterol; 2014 Nov; 20(42):15756-62. PubMed ID: 25400460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
    Hendriks ME; van Westerloo DJ; Portegies P
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2701-6. PubMed ID: 18225787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ammonia levels and the severity of hepatic encephalopathy.
    Qureshi MO; Khokhar N; Shafqat F
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuropsychological changes and psychiatric complications observed in a population of patients with liver transplantation].
    Kwantes N; Vindreau C; Samuel D; Bismuth H; Ginestet D
    Ann Med Psychol (Paris); 1990 Jan; 148(1):97-104. PubMed ID: 2191623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.